Diabetes 57:269-275, 2008 DOI: 10.2337/db07-1095 © 2008 by the American Diabetes Association
Unaltered Diabetes Presentation in NOD Mice Lacking the Vitamin D Receptor
1 Laboratory of Experimental Medicine and Endocrinology, Department of Experimental Medicine, Katholieke Universiteit Leuven, Leuven, Belgium Address correspondence and reprint requests to Chantal Mathieu, MD, PhD, LEGENDO, Campus Gasthuisberg O&N1, Katholieke Universiteit Leuven, Herestraat 49, 3000 Leuven, Belgium. E-mail: chantal.mathieu{at}med.kuleuven.be
Key Words: AUC, area under the curve 1,25-dihydroxyvitamin D3, 1,25(OH)2D3 CCL2, CC chemokine ligand 2 IL, interleukin LPS, lipopolysaccharide NF-
OBJECTIVE— Vitamin D deficiency increases risk for type 1 diabetes in genetically predisposed individuals, while high doses of 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] prevent insulitis and diabetes in NOD mice. RESEARCH DESIGN AND METHODS— Since 1,25(OH)2D3 regulates gene transcription through the vitamin D receptor (VDR), we investigated the role of VDR in diabetes development by creating NOD mice without functional VDR.
RESULTS— VDR–/– NOD mice are rachitic and have lower numbers of putative regulator cells [TCR- CONCLUSIONS— Despite aggravating known immune abnormalities in NOD mice, disruption of VDR does not alter disease presentation in NOD mice in contrast to the more aggressive diabetes presentation in vitamin D–deficient NOD mice.
|
|
|
|||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||